740
Participants
Start Date
September 30, 2014
Primary Completion Date
August 31, 2015
Study Completion Date
October 31, 2016
Dupilumab
Subcutaneous injection in the different quadrants of the abdomen (avoiding navel and waist areas) and upper thighs
Placebo (for Dupilumab)
Subcutaneous injection in the different quadrants of the abdomen (avoiding navel and waist areas) and upper thighs
Topical Corticosteroid (TCS)
All participants were required to treatment with a (TCS) using a standardized regimen. It was recommended that participants use triamcinolone acetonide 0.1% cream or fluocinolone acetonide 0.025% ointment for medium potency, and hydrocortisone 1% cream for low potency.
Phoenix
Hot Springs
Little Rock
Encinitas
Oceanside
Palmdale
San Diego
New Haven
Trumbull
Edgewater
Lake Worth
Miami Lakes
Orlando
Tampa
Alpharetta
Columbus
Savannah
West Dundee
Carmel
New Albany
Rockville
Ann Arbor
Bay City
Edina
Fridley
St Louis
Omaha
Henderson
Verona
Albuquerque
Corning
New York
Smithtown
Stony Brook
Cincinnati
Norman
Oklahoma City
Lake Oswego
Portland
Exton
Hazleton
Philadelphia
Austin
Dallas
West Jordan
South Burlington
Henrico
Norfolk
Richmond
Spokane
Phillip
Kogarah
Benowa
Dulwich
Hectorville
Carlton
Surrey
Vancouver
Ajax
Barrie
Hamilton
Markham
North Bay
Oakville
Ottawa
Peterborough
Richmond Hill
Toronto
Waterloo
Windsor
Drummondville
Québec
Hradec Králové
Náchod
Prague
Svitavy
Ústí nad Labem
Orosháza
Szolnok
Veszprém
Budapest
Ancona
Bologna
Brescia
Novara
Pavia
Perugia
Roma
Kitakyushu
Amagasaki
Yokohama
Kamimashiki-gun
Saitama-shi
Yaizu
Koto-ku
Setagaya-ku
Adachi-ku
Chiyoda-ku
Nakano
Nerima-ku
Shibuya-ku
Shinagawa-ku
Shinjuku-ku
Suginami-ku
Fukuoka
Breda
Amsterdam
Rotterdam
Groningen
Utrecht
Dunedin
Auckland
Poznan
Krakow
Wroclaw
Lublin
Warsaw
Strzelce Opolskie
Iwonicz-Zdrój
Bialystok
Gdansk
Katowice
Szczecin
Gdynia
Lodz
Skarżysko-Kamienna
Brasov
Bucharest
Cluj-Napoca
Craiova
Târgu Mureş
Bucheon-si
Suwon
Seoul
Seodaemun-gu
Uijeongbu-si
Barcelona
Alicante
Madrid
Dundee
Edgbaston
Glasgow
Sidcup
Northwood
Liverpool
Manchester
Reading
Salford
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY